ROL vs XRAY · P/E 41, rev $3.39B vs rev $3.68B
Rollins Inc (ROL) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the ROL and XRAY stock pages for the full models.
Not investment advice.